Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
Nippon India Pharma Fund Direct Plan Bonus Plan Bonus
Nippon India Mutual FundSectoral Pharma and HealthcareDirectBonus
NAV
₹643.3432
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +10.50% | — | — |
| 3 year | +19.01% | — | — |
| 5 year | +14.56% | — | — |
- Sharpe
- 1.03
- Std dev
- 15.79%
- Beta
- 0.90
All Sectoral Pharma and Healthcare funds · Nippon India Mutual Fund
Returns
From NAVs through 18 Aug 2026
1Y
+10.50%
Total
3Y
+19.01%
p.a.
5Y
+14.56%
p.a.
SI
+14.70%
p.a.
Calendar years
-9.06%2022
+40.36%2023
+35.26%2024
-2.46%2025
+12.90%2026 YTD
Rolling 1-year · 51 overlapping windows
-12.24%avg +16.43%+62.98%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹8635.75 Cr
Expense ratio
0.79%
Exit load
None
Lock-in
None
Launched01 Jan 2013
StructureOpen Ended
Entry loadNone
ISININF204K01I27
Where the money is invested
Split by asset type.
By asset type
Equity97.92%
Cash2.08%
What the fund holds
37 holdings · portfolio as on 30 May 2026
- 13.35%Sun Pharmaceuticals Industries LtdHealthcare
- 7.31%Lupin LtdHealthcare
- 6.72%Dr Reddy's Laboratories LtdHealthcare
- 6.16%Cipla LtdHealthcare
- 5.8%Divi's Laboratories LtdHealthcare
- 5.2%Apollo Hospitals Enterprise LtdHealthcare
- 3.94%Mankind Pharma LtdHealthcare
- 3.68%Medplus Health Services LtdHealthcare
- 3.43%Sai Life Sciences LtdHealthcare
- 3.21%Ajanta Pharma LtdHealthcare
Concentration
Top 5 weight
39.33%
Top 10 weight
58.78%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
1.03
Better than category avg 0.98
Sortino
1.34
Return per unit of downside risk
Alpha
-0.27
Return above the benchmark
Risk
Std deviation
15.79%
How much returns swing
Beta
0.9
Better than category avg 0.95
R-squared
94.6%
How closely it tracks the benchmark
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare- ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare- Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
Rate
+19.01%
Invested
₹6,00,000
Illustrated
₹17,93,537
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- directIDCWNippon India Pharma Fund Direct Plan Dividend Plan IDCW PayoutNAV ₹170.0365
- regularbonusNippon India Pharma Fund - Bonus PlanNAV ₹515.1984
- regularGrowthNippon India Pharma Fund - Growth Plan - Growth OptionNAV ₹515.1984
- regularIDCWNippon India Pharma Fund - IDCW Payout OptionNAV ₹120.0798
- directGrowthNippon India Pharma Fund Direct Plan Growth Plan - Growth Option GrowthNAV ₹575.842
FAQ
What is Nippon India Pharma Fund Direct Plan Bonus Plan Bonus NAV today?
- The latest NAV of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus is ₹643.3432 as on 18 Aug 2026.
How has Nippon India Pharma Fund Direct Plan Bonus Plan Bonus performed vs its category?
- 1-year return +10.50%. Past performance does not guarantee future returns.
What are the returns of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus?
- Trailing returns from published NAVs: 1 year +10.50%, 3 year +19.01% a year, 5 year +14.56% a year, since our first NAV +14.70% a year. Past performance does not guarantee future returns.
How would a SIP in Nippon India Pharma Fund Direct Plan Bonus Plan Bonus have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +19.01%. It is not a forecast.
What is the expense ratio and fund size of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus?
- For Nippon India Pharma Fund Direct Plan Bonus Plan Bonus, the expense ratio is 0.79% and fund size (AUM) is ₹8635.75 Cr.
What is the ISIN of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus?
- The ISIN for Nippon India Pharma Fund Direct Plan Bonus Plan Bonus is INF204K01I27.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.